Yumanity Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch YMTX and buy or sell other stocks, options, and ETFs commission-free!About YMTX
Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb.
CEOShawn P. Iadonato, PhD
CEOShawn P. Iadonato, PhD
Employees11
Employees11
HeadquartersMercer Island, Washington
HeadquartersMercer Island, Washington
Founded2008
Founded2008
Employees11
Employees11
YMTX Key Statistics
Market cap19.65M
Market cap19.65M
Price-Earnings ratio-0.36
Price-Earnings ratio-0.36
Dividend yield—
Dividend yield—
Average volume1.56M
Average volume1.56M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.39
52 Week high$5.39
52 Week low$0.3339
52 Week low$0.3339